Zoetis' Chinese joint venture has received the approval from China's Ministry of Agriculture for Rui Lan An, a specialized vaccine to help control the highly pathogenic porcine reproductive and respiratory syndrome.
Rui Lan An, which will be launched later this month, is the first vaccine to emerge from the joint venture that was established to develop and manufacture animal vaccines specifically designed to answer the needs of China's livestock producers. It will help China's pork producers meet increasing demand in China for quality, affordable pork.
Vaccines for swine have high growth potential as China is the world's leading pork producing nation, with an annual population of more than 685 million pigs in 2012. The joint venture provides a strategic platform for growth in China where the animal health industry is valued at USD1.8 billion and is expected to grow at 9.3% year over year in the next 5 years.